Elequin Capital’s Ascendis Pharma A/S ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.8K Sell
21
-30
-59% -$6.72K ﹤0.01% 387
2025
Q4
$10.9K Buy
+51
New +$10.5K ﹤0.01% 234
2025
Q1
Sell
-53
Closed -$7.3K 345
2024
Q4
$7.3K Buy
53
+47
+783% +$6.18K ﹤0.01% 376
2024
Q3
$896 Buy
+6
New +$810 ﹤0.01% 335
2024
Q2
Sell
-50
Closed -$7.56K 202
2024
Q1
$7.56K Buy
+50
New +$7.14K ﹤0.01% 126
2023
Q3
Sell
-44
Closed -$3.93K 406
2023
Q2
$3.93K Buy
+44
New +$3.83K ﹤0.01% 394
2022
Q4
Sell
-76
Closed -$8K 626
2022
Q3
$8K Sell
76
-37
-33% -$3.51K ﹤0.01% 285
2022
Q2
$11K Buy
113
+94
+495% +$8.86K ﹤0.01% 229
2022
Q1
$2K Buy
+19
New +$2.2K ﹤0.01% 252

Other funds holding ASND